APO GLP 5 (Glipizide 5 mg)

Pill imprint APO GLP 5 has been identified as Glipizide 5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO GLP 5

Glipizide 5 mg APO GLP 5
Glipizide 5 mg APO GLP 5
Glipizide
Imprint:
APO
GLP 5
Strength:
5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corporation
National Drug Code (NDC):
60505-0141
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-7924 Major Pharmaceuticals
66267-0100 Nucare Pharmaceuticals Inc (repackager)
66336-0730 Dispensing Solutions Inc. (repackager)
54868-3318 Physicians Total Care Inc (repackager)
21695-0469 Rebel Distributors Corp (repackager)
49999-0108 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)